Gep Net
Sayfa Sayısı: 202
Baskı Yılı: 2006
Dili: Türkçe
Yayınevi: İstanbul Medikal Yayıncılık
GEP-NETs represent a diverse family of tumors that arise in the gastrointestinal (GI) tract or pancreas. 1-3 The overall incidence of NETs across all stages, sites, and grades has increased nearly Foregut GEP-NET (foregut tumors can conceptually encompasses not only NETs of the stomach and proximal duodenum, but also the pancreas, and even thymus, lung and bronchus) [citation needed] Pancreatic endocrine tumors (if considered separately from foregut GEP-NET) Midgut GEP-NET (from distal half of 2nd part of the duodenum to the proximal two
Tecnología
PC e Mac
Lea el libro electrónico inmediatamente después de descargarlo mediante "Leer ahora" en su navegador o con el software de lectura gratuito Adobe Digital Editions.
iOS & Android
Para tabletas y teléfonos inteligentes: nuestra aplicación gratuita de lectura tolino
eBook Reader
Descargue el libro electrónico directamente al lector en la tienda www.matchado.com.au o transfiéralo con el software gratuito Sony READER FOR PC / Mac o Adobe Digital Editions.
Reader
Después de la sincronización automática, abra el libro electrónico en el lector o transfiéralo manualmente a su dispositivo tolino utilizando el software gratuito Adobe Digital Editions.
Mercado
Notas actuales
SOMATULINE DEPOT is a prescription medicine used in adults for: the treatment of a type of cancer known as neuroendocrine tumors, from the gastrointestinal tract or the pancreas (GEP-NETs) that has spread or cannot be removed by surgery; and the treatment of carcinoid syndrome to reduce the need for the use of short-acting somatostatin medicine. Most GEP-NET patients have tumors that express somatostatin receptors. In June 2016, FDA approved a diagnostic imaging method that uses dotatate tagged with a different radioactive element, gallium-68, to locate somatostatin receptor–positive tumors using positron emission tomography (PET) scans.
The 2010 WHO NET classification system was applied to all of GEP-NETs, using hematoxylin and eosin-stained slides and the immunohistochemistry (MIB1 ... 6 Oct 2018 ... ... with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to receive lanreotide after octreotide can be a potential therapeutic option.
Here at GepNet, Inc., we offer a wide range of solutions for the business world. We are an end to end provider.
6 Oct 2018 ... ... with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to receive lanreotide after octreotide can be a potential therapeutic option. 8 Oct 2018 ... Gastroenteropancreatic NETs (GEP‐NETs) include carcinoid tumors of the gastrointestinal tract and pancreatic NETs (pNETs).1 Whereas ...
Section 2. Biology and Histopathology of GEP-NETs Dr Scoazec details the role of the pathologist in the multidisciplinary team and explains the histopathologic findings associated with the diagnosis and prognosis of GEP-NETs. Jean-Yves Scoazec, MD